CLINICAL PHARMACISTS’ IMPACT ON 30-DAY READMISSION RATE AFTER COPD HOSPITALIZATION

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HPS-020
• By: CORALIC, Aida (United States)
• Co-author(s): Aida Coralic: Pharmacy, Houston Methodist Hospital, Houston, United States
  Kathryn Pidcock: Pharmacy, Houston Methodist Hospital, HOUSTON, United States
  Diana Kurian: Pharmacy, Houston Methodist Hospital, Houston, United States
  Rejena Azad: Pharmacy, Houston Methodist Hospital, Houston, United States
  Rafael Felippi: Pharmacy, Houston Methodist Hospital, Houston, United States
  Robert Jackson: Medicine, Houston Methodist Hospital, Houston, United States
  
• Abstract:

  Background

  In the U.S., about 22% of patients admitted for acute exacerbations of COPD (AECOPD) are readmitted within 30 days, and 10-55% of these readmissions are preventable.  

  Methods

  We conducted a prospective, single cohort, descriptive study at a large academic institution, during March 2017 through June 2018.  Patients admitted with an AECOPD

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login